Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ACAIOTCMKTS:ARTHOTCMKTS:HDIIOTCMKTS:RCAR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACAISafeplus International$0.00$0.00▼$0.00$3K1.12N/AN/AARTHArch Therapeutics$0.00$0.14$0.16▼$1.57$6K4.024,068 shs600 shsHDIIHypertension Diagnostics$0.00$0.00▼$0.00$5K-0.07193,800 shsN/ARCARRenovaCare$0.00$0.00▼$0.30$9K-99.34N/AN/AA Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACAISafeplus International0.00%0.00%0.00%0.00%-20.00%ARTHArch Therapeutics0.00%0.00%+33.33%-99.48%-99.89%HDIIHypertension Diagnostics0.00%0.00%0.00%0.00%-50.00%RCARRenovaCare0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationACAISafeplus InternationalN/AN/AN/AN/AN/AN/AN/AN/AARTHArch TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AHDIIHypertension DiagnosticsN/AN/AN/AN/AN/AN/AN/AN/ARCARRenovaCareN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceACAISafeplus International 0.00N/AN/AN/AARTHArch Therapeutics 0.00N/AN/AN/AHDIIHypertension Diagnostics 0.00N/AN/AN/ARCARRenovaCare 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACAISafeplus InternationalN/AN/AN/AN/AN/AN/AARTHArch Therapeutics$80K0.07N/AN/A($2.43) per share0.00HDIIHypertension DiagnosticsN/AN/AN/AN/AN/AN/ARCARRenovaCareN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACAISafeplus InternationalN/AN/A0.00N/AN/AN/AN/AN/AN/AARTHArch Therapeutics-$6.98MN/A0.00∞N/A-8,257.70%N/A-730.22%8/18/2025 (Estimated)HDIIHypertension DiagnosticsN/AN/A0.00N/AN/AN/AN/AN/AN/ARCARRenovaCareN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACAISafeplus InternationalN/AN/AN/AN/AN/AARTHArch TherapeuticsN/AN/AN/AN/AN/AHDIIHypertension DiagnosticsN/AN/AN/AN/AN/ARCARRenovaCareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACAISafeplus InternationalN/AN/AN/AARTHArch TherapeuticsN/A0.100.01HDIIHypertension DiagnosticsN/AN/AN/ARCARRenovaCareN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACAISafeplus InternationalN/AARTHArch Therapeutics6.91%HDIIHypertension DiagnosticsN/ARCARRenovaCareN/AInsider OwnershipCompanyInsider OwnershipACAISafeplus International4.02%ARTHArch Therapeutics4.50%HDIIHypertension Diagnostics40.00%RCARRenovaCare0.86%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACAISafeplus International225.38 million24.36 millionNot OptionableARTHArch Therapeutics104.74 million4.53 millionNot OptionableHDIIHypertension Diagnostics2,01752.39 million170.87 millionNot OptionableRCARRenovaCare187.35 millionN/ANot OptionableACAI, RCAR, ARTH, and HDII HeadlinesRecent News About These CompaniesRenovaCare Inc. Provides Notice of Proposed Derivative Settlement to All Record Holders and Beneficial Owners of RenovaCare, Inc.February 12, 2025 | businesswire.comHagens Berman Sobol Shapiro LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of RenovaCare Securities - RCARJanuary 17, 2025 | globenewswire.comRenovaCare $2M Deal in Stock Promotion LawsuitSeptember 25, 2024 | usaherald.comCompare Car Insurance Rates for August 2024August 15, 2024 | nerdwallet.comThe Most Luxurious Cars, SUVs, and Trucks You Can Buy in 2024July 27, 2024 | roadandtrack.comRenovaCare Inc.July 23, 2024 | wsj.comRenovaCare, Inc. (RCAR)May 24, 2024 | finance.yahoo.comRenovaCare Stock (OTC:RCAR), Quotes and News SummaryMay 24, 2024 | benzinga.comEarly Cars: Fact Sheet for ChildrenMay 14, 2024 | si.eduSerra ToyotaApril 22, 2024 | cars.comBest Midsize Car for 2022April 19, 2024 | cnet.comUsed cars for sale under $5,000 near meApril 19, 2024 | cars.comCheapest Car Insurance New JerseyApril 18, 2024 | marketwatch.comThe best booster car seats of 2024April 17, 2024 | autoblog.comUsed cars for sale under £5,000April 10, 2024 | motors.co.ukBest Hybrid Cars for 2024 & 2025April 9, 2024 | autoweek.comEuro Car Parts Discount Codes April 2024April 8, 2024 | independent.co.ukBitcoin Laundering, 'Gucci Goddess' Army Swindle And Healthcare 'Pump And Dump' Scam: Financial Crime WeeklyMarch 1, 2024 | benzinga.comRenovaCare, Inc. (RCAR) Stock Historical Prices & Data - Yahoo FinanceOctober 12, 2023 | finance.yahoo.comGlobal Technology Acquisition Corp I Unit (GTACU)August 9, 2023 | investing.comMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeAnalysts Think These Stocks Could More Than Double in ValueBy Nathan Reiff | May 23, 2025View Analysts Think These Stocks Could More Than Double in ValueIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s WatchingBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsApple’s Quiet HomePad Delay Could Be Its Loudest Move YetBy Chris Markoch | June 1, 2025View Apple’s Quiet HomePad Delay Could Be Its Loudest Move YetACAI, RCAR, ARTH, and HDII Company DescriptionsSafeplus International OTCMKTS:ACAISafeplus International Holdings Limited develops and markets various technologies for the medical device industries. It is seeking partners to monetize its patented technologies, including biothermal power supply and pulsewidth modulation technology to enhance the performance of pacemakers and neurostimulators, and photonics and nanomaterials patents. The company was formerly known as Biophan Technologies, Inc. and changed its name to Safeplus International Holdings Limited in September 2020. Safeplus International Holdings Limited was founded in 1963 and is based in Pittsford, New York.Arch Therapeutics OTCMKTS:ARTH$0.0012 0.00 (0.00%) As of 06/13/2025Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. The company's flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. It is also involved in the development of AC5-G for gastrointestinal endoscopic procedures, and AC5-V and AC5 surgical hemostat for hemostasis inside the body. The company was founded in 2006 and is based in Framingham, Massachusetts.Hypertension Diagnostics OTCMKTS:HDIIHypertension Diagnostics, Inc. designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries in the United States and internationally. It offers CVProfilor, which allows a physician to non-invasively assess the elasticity of small and large arteries, of which small artery elasticity is the earliest and sensitive marker of cardiovascular disease. The company offers CVProfilor DO-2020, which provides a patient's arterial elasticity indices used in the assessment for underlying vascular disease; CVProfilor MD-3000 that offers a sensitive and specific guide to the presence of blood vessel disease; and HD/PulseWave CR-2000 research cardiovascular profiling system, which provides researchers and scientists with a non-invasive means to assess arterial elasticity in support of human research in various areas. Its products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and C1-large and C2-small artery elasticity indices. The company sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms. It markets its products through a representative organization in the United States. Hypertension Diagnostics, Inc. was founded in 1988 and is based in Richmond Hill, Canada.RenovaCare OTCMKTS:RCARRenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name RenovaCare, Inc.,to RenovaCare, Inc. in January 2014. RenovaCare, Inc. was incorporated in 1983 and is based in Scottsdale, Arizona. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New Catalysts to Drive NVIDIA’s Stock Price Even Higher Palantir Defies Bears, Leads S&P 500 in 2025 AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? Why Analysts Are Bullish on Celsius Stock After 30% Drop 3 Stocks With Rising Dividends Investors Shouldn’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
